review of glp 1 GLP-1 agonists and changes in body mass and composition in adults with overweight or obesity with or without type 2 diabetes mellitus: a systematic and meta-analysis What Happens After GLP-1 Weight

We have witnessed improved joint mobility in patients using GLP-1 therapy, offering a comprehensive approach to managing joint pain alongside other metabolic benefits

Providers also review medical history, current health conditions, previous weight loss efforts, medication safety, and treatment goals

Dr Paula Diab gives an overview of GLP-1 drugs, their approved uses, and who might benefit the most

Medications can also contribute to cognitive symptoms, either through direct effects on neurotransmitter systems or indirect metabolic consequences

Based on previous studies examining the relationship between the gut-brain axis and cognitive functions [102, 103], unhealthy eating habits and poor diet quality may worsen brain fog symptoms

The comparison between oral and injectable tirzepatide shows that injectable delivery remains the gold standard for maximum weight loss efficacy